Reviews of PSIL-006 – Non-hallucinogenic psilocybin derivative / neuroplastogen
No reviews yet. Share the first one.
PSIL-006 – Non-hallucinogenic psilocybin derivative / neuroplastogen by Psilera, Inc.
Investigational candidate being studied preclinically for frontotemporal dementia and alcohol use disorder. First-in-human testing is anticipated in 2027. Investigational; not for sale.
Guides about PSIL-006 – Non-hallucinogenic psilocybin derivative / neuroplastogen